EXTON, Pa., Aug. 3 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY), a medical device company primarily focused on regenerative medicine, today announced that it will release its earnings results for its fourth quarter and fiscal year ended June 30, 2010 at 7:30 A.M. Eastern Time on Monday, August 23, 2010.
Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Monday, August 23, 2010 at 9:00 A.M. Eastern Time.
To participate in the teleconference call, dial 1-612-234-9959. The teleconference call will also be available for replay starting Monday, August 23, 2010 at 11:00 A.M. Eastern Time through Monday, August 30, 2010 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 166835.
Individuals interested in listening to the teleconference may also do so over the Internet at www.kenseynash.com. To listen to the live teleconference call, please go to the www.kenseynash.com website and choose the Investor Relations page. Please allow 15 minutes prior to the start of the call to register and download and/or install any necessary software. A replay of the teleconference will be archived on the www.kenseynash.com website and may be accessed following the teleconference.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including, the cardiology, orthopedic, sports medicine, spine, general surgery and endovascular markets.
|SOURCE Kensey Nash Corporation|
Copyright©2010 PR Newswire.
All rights reserved